Hye-Jung Kim

Company: Dana-Farber Cancer Institute

Job title: Lead Investigator

Seminars:

Helios, Treg Stability & Contribution to Anti-Tumor Immunity 12:00 pm

Discussing Helios as a common transcription factor for CD8 and CD4 Treg Targeting Helios to achieve selective induction of Treg instability under inflammatory conditionsRead more

day: Pre-Conference Focus Day